Stem Cell therapy in ischemic stroke: Role of IV and intra-arterial therapy

Neurology

Volumn 79, Issue 13 SUPPL. 1, 2012, Pages

  Misra, Vivek ^a,b   Ritchie, Michael M ^c,f   Stone, Laura L ^d,f   Low, Walter C ^c,d,e,f   Janardhan, Vallabh ^a  

^a HOSPITAL CORPORATION OF AMERICA   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c Stem Cell Institute   (United States)

^d Graduate Program in Neuroscience   (United States)

^e Department of Neurosurgery ^*  (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW CELL; BRAIN ISCHEMIA; CELL TYPE; HEART DISEASE; HUMAN; MESENCHYMAL STROMA CELL; NEUROPROTECTION; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; ARTICLE; BLOOD CLOT LYSIS; BONE MARROW; CLINICAL TRIAL; EMBRYONIC STEM CELL; MEDLINE; NONHUMAN; SOMATIC CELL; THROMBECTOMY; UMBILICAL CORD;

EID: 84867545489     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31826959d2     Document Type: Article

References (41)

1. Savitz SI, Chopp M, Deans R, Carmichael ST, Phinney D, Wechsler L. Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II. Stroke 2011;42:825-829.
2. Misra V, Yang B, Sharma S, Savitz SI. Cell-based therapy for stroke. In: Cox C, editor. Progenitor Cell Therapy for Neurological Injury. New York: Springer; 2011:143-162.
3. Li Y, Chopp M, Chen J, et al. Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J Cereb Blood Flow Metab 2000;20:1311-1319.
4. Kondziolka D, Steinberg GK, Wechsler L, et al. Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg 2005;103:38-45.
5. Savitz SI, Dinsmore J, Wu J, Henderson GV, Stieg P, Caplan LR. Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study. Cerebrovasc Dis 2005;20:101-107.
6. Jiang Q, Zhang ZG, Ding GL, et al. Investigation of neural progenitor cell induced angiogenesis after embolic stroke in rat using MRI. Neuroimage 2005;28:698-707.
7. Modo M, Stroemer RP, Tang E, Patel S, Hodges H. Effects of implantation site of stem cell grafts on behavioral recovery from stroke damage. Stroke 2002;33:2270-2278.
8. Rabinovich SS, Seledtsov VI, Banul NV, et al. Cell therapy of brain stroke. Bull Exp Biol Med 2005;139:126-128.
9. Hauger O, Frost EE, van Heeswijk R, et al. MR evaluation of the glomerular homing of magnetically labeled mesenchymal stem cells in a rat model of nephropathy. Radiology 2006;238:200-210.
10. Kraitchman DL, Tatsumi M, Gilson WD, et al. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 2005;112:1451-1461.
11. Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005;57:874-882.
12. Lee JS, Hong JM, Moon GJ, Lee PH, Ahn YH, Bang OY; STARTING Collaborators. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 2010;28:1099-1106.
13. Honmou O, Houkin K, Matsunaga T, et al. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 2011;134:1790-1807.
14. Savitz SI, Misra V, Kasam M, et al. Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann Neurol 2011;70:59-69.
15. Yang B, Strong R, Sharma S, et al. Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke. J Neurosci Res 2011;89:833-839.
16. Guzman R, De Los Angeles A, Cheshier S, et al. Intracarotid injection of fluorescence activated cell-sorted CD49d-positive neural stem cells improves targeted cell delivery and behavior after stroke in a mouse stroke model. Stroke 2008;39:1300-1306.
17. Shen LH, Li Y, Chen J, et al. Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke. Neuroscience 2006;137:393-399.
18. Liu H, Honmou O, Harada K, et al. Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain 2006;129:2734-2745.
19. Li L, Jiang Q, Ding G, et al. Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study. J Cereb Blood Flow Metab 2010;30:653-662.
20. Kamiya N, Ueda M, Igarashi H, et al. Intra-arterial transplantation of bone marrow mononuclear cells immediately after reperfusion decreases brain injury after focal ischemia in rats. Life Sci 2008;83:433-437.
21. Walczak P, Zhang J, Gilad AA, et al. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 2008;39:1569-1574.
22. Chua JY, Pendharkar AV, Wang N, et al. Intra-arterial injection of neural stem cells using a microneedle technique does not cause microembolic strokes. J Cereb Blood Flow Metab 2011;31:1263-1271.
23. Xiao J, Nan ZH, Motooka Y, Low WC. Transplantation of a novel cell line population of umbilical cord blood stem cells ameliorates neurological deficits associated with ischemic brain injury. Stem Cells Dev 2005;14:722-733.
24. Ramos-Cabrer P, Justicia C, Wiedermann D, Hoehn M. Stem cell mediation of functional recovery after stroke. PLoS One 2010;5:e12779.
25. Daadi MM, Davis AS, Arac A, et al. Human neural stem cell grafts modify microglial response and enhance axonal sprouting in neonatal hypoxic-ischemic brain injury. Stroke 2010;41:516-523.
26. Yang M, Wei X, Li J, Heine LA, Rosenwasser R, Lacovitti L. Changes in host blood factors and brain glia accompanying the functional recovery after systemic administration of bone marrow stem cells in ischemic stroke rats. Cell Transp 2010;9:1973-1984.
27. Walker PA, Letourneau PA, Bedi S, Shah SK, Jimenez F, Cox CS. Progenitor cells as remote "bioreactors": neuroprotection via modulation of the systemic inflammatory response. World J Stem Cells 2011;3:9-18.
28. Nan ZH, Grande A, Sanberg CD, Sanberg PR, Low WC. Infusion of human umbilical cord blood ameliorates neurologic deficits in rats with hemorrhagic brain injury. Ann NY Acad Sci 2005;1049:84-96.
29. Kranz A, Wagner DC, Kamprad M, et al. Transplantation of placenta-derived mesenchymal stromal cells upon experimental stroke in rats. Brain Res 2010;1315:128-136.
30. Vendrame M, Cassady J, Newcomb J, et al. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke 2004;35:2390-2395.
31. Honma T, Honmou O, Iihoshi S, et al. Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Exp Neurol 2006;199:56-66.
32. Dimmeler S, Zeiher AM. Cell therapy of acute myocardial infarction: open questions. Cardiology 2009;113:155-160.
33. Lawall H, Bramlage P, Amann B. Stem cell and progenitor cell therapy in peripheral artery disease: a critical appraisal. Thromb Haemost 2010;103:696-709.
34. Mendonça ML, Freitas GR, Silva SA, et al. Safety of intraarterial autologous bone marrow mononuclear cell transplantation for acute ischemic stroke. Arq Bras Cardiol 2006;86:52-55.
35. Correa PL, Mesquita CT, Felix RM, et al. Assessment of intra-arterial injected autologous bone marrow mononuclear cell distribution by radioactive labeling in acute ischemic stroke. Clin Nucl Med 2007;32:839-841.
36. Battistella V, de Freitas GR, da Fonseca LM, et al. Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke. Regen Med 2011;6:45-52.
37. Assmus B, Schächinger V, Teupe C, et al. Transplantation Of Progenitor Cells And Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002;106:3009-3017.
38. Terai Y, Kanemura M, Sasaki H, et al. Long-term follow-up of neoadjuvant intraarterial chemotherapy using an original four-lumen double-balloon (4L-DB) catheter for locally advanced uterine cervical cancer. Int J Clin Oncol 2009;14:56-62.
39. Janardhan V, Biondi A, Riina H, Sanelli PC, Stieg PE, Gobin YP. Vasospasm in aneurysmal subarachnoid hemorrhage: diagnosis, prevention, and management. Neuroimaging Clin North Am 2006;16:483-496.
40. El Khoury R, Misra V, Sharma S, et al. The effect of transcatheter injections on cell viability and cytokine release of mononuclear cells. AJNR Am J Neuroradiol 2010;31:1488-1492.
41. Janardhan V, Qureshi AI, Low WC. Intravascular delivery systems for stem cell transplantation for neurological disorders. In: Low WC, Verfaillie CM, eds. Stem Cells and Regenerative Medicine. Singapore: World Scientific Publishing; 2008:355-396.